Fiduciary Trust’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,103
Closed -$74.6K 858
2025
Q1
$74.6K Hold
15,103
﹤0.01% 810
2024
Q4
$44.4K Hold
15,103
﹤0.01% 685
2024
Q3
$71.3K Hold
15,103
﹤0.01% 646
2024
Q2
$58.1K Hold
15,103
﹤0.01% 622
2024
Q1
$80.8K Hold
15,103
﹤0.01% 635
2023
Q4
$64.5K Hold
15,103
﹤0.01% 617
2023
Q3
$59.2K Hold
15,103
﹤0.01% 603
2023
Q2
$153K Hold
15,103
﹤0.01% 609
2023
Q1
$154K Hold
15,103
﹤0.01% 598
2022
Q4
$142K Buy
15,103
+2,043
+16% +$28.8K ﹤0.01% 610
2022
Q3
$190K Buy
13,060
+2,043
+19% +$30.3K ﹤0.01% 588
2022
Q2
$145K Hold
11,017
﹤0.01% 609
2022
Q1
$188K Sell
11,017
-6,129
-36% -$104K ﹤0.01% 644
2021
Q4
$439K Buy
+17,146
New +$535K 0.01% 489

Other funds holding TSVT

Fiduciary Trust's TSVT Position: Q2 2025 in Review

Fiduciary Trust sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 15,103 shares — an estimated $74.6K sold.

Fiduciary Trust first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $439K in Q4 2021. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Fiduciary Trust reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Fiduciary Trust sold 15,103 2seventy bio shares in Q2 2025, an estimated $74.6K.
  • Fiduciary Trust first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • Fiduciary Trust's 2seventy bio position peaked at $439K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Fiduciary Trust's 13F filing for Q2 2025, filed 14 Aug 2025.